S ince the early 1970s, one of the more exciting developments in nutrition research has been the demonstration that brain function may be influenced by the availability of various nutrients in the diet (for review see Ref. 3). Midway through the 1970s, Gessa et al. (5) first demonstrated that the acute administration of a mixture of essential amino acids lacking tryptophan (TRP) produced a specific and long-lasting reduction of brain TRP and serotonin (5-HT) levels in rats. This result opened up an active field of research. On the one hand, attempts have been made to understand the mechanisms through which tryptophan-free amino acid mixtures reduce brain 5-HT levels, and on the other hand, TRP-free diets have offered a specific and nontoxic tool for studying the role of 5-HT in the regulation of different physiological parameters and behavioral indexes in laboratory animals and humans.
Biochemical effects of TRP-free diets
The TRP-free amino acid mixture described by Gessa et al. (5) contained all of the essential amino acids except TRP, plus glycine as integrator of nitric groups. The composition of the mixture was (in %) 45.9 L-glycine, 15 .3 L-lysine, 3 .0 L-histidine, 6.1 L-methionine, 6.9 L-phenylalanine, 3 .0 L-leucine, 6.1 L-isoleucine, 5.3 L-threonine, 7.6 L-valine, and 0.8 arginine. The administration of this TRP-free amino acid mixture in rats produced a sharp drop in the concentration of serum TRP, associated with a decrease in brain TRP, 5-HT, and 5-hydroxyindolacetic acid (5-HIAA) levels in rat brain. The same effect was observed either in response to a balanced diet in which TRP was removed or in response to foods deficient in this essential amino acid (1) . Interestingly, Young et al. (13) found that after the administration of a TRP-free mixture of amino acids, the concentration of TRP and 5-HIAA decreased in the cerebrospinal fluid of primates but the concentration of tyrosine and the catecholamine metabolites homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol did not, suggesting that the catecholaminergic system is not influenced by the mixture.
In our laboratory, the TRP-free amino acid mixture was first used in human subjects to evaluate possible mental changes (2) . The mixture contained all essential amino acids, the composition of which (in %) was: 33 L-glycine, 8.8 L-lysine, 12 Lmethionine, 12 L-phenylalanine, 12 L-leucine, 7.7 L-isoleucine, 5.5 L-threonine, and 8.8 L-valine. We observed that 18.2 g of the above mixture caused a substantial decline in plasma TRP (60% of initial value 4 h after the ingestion), which was related to a high level of anxiety (see below). Inasmuch as the TRP-free amino acid mixtures in humans produced a fall in serum TRP similar to that obtained in laboratory animals, this indicated that such a technique offered a nonpharmacological means for effectively decreasing brain TRP content and presumably brain 5-HT. Young et al. (14) also used a TRP-free amino acid mixture in humans, but the composition was different from the one used by our group. They used all of the amino acids (except aspartic and glutamic acid) in the same proportions occurring in human milk. Five hours after the ingestion of this TRP-free amino acid mixture, a 76% decrease of plasma TRP was found.
Recently, Nishizawa et al. (9) reported an in vivo measurement of 5-HT synthesis in the human brain with the use of positron emission tomography. They measured the rate of 5-HT synthesis in baseline conditions and after the ingestion of the TRP-free amino acid mixture. Dietary depletion of TRP lowered the rate of brain 5-HT synthesis in male and female subjects. The TRP-free diet also produced a decline in cerebrospinal fluid TRP and 5-HIAA in healthy human subjects. These results clearly indicate that TRP depletion in humans induces a decline in 5-HT synthesis and turnover as well as a probable decrease in the neuronal release of this amine.
The role of TRP in the regulation of central 5-HT transmission
It has been suggested that the rate at which 5-HT is released varies with that of 5-HT synthesis. This assumption is based on studies reporting modifications in some behavioral indexes related to 5-HT function when plasma and brain TRP concentrations are altered in vivo. Recently, Stancampiano et al. (12) , using in vivo brain microdialysis, examined the effect of the reduction of brain TRP content on the release of endogenous 5-HT. They demonstrated for the first time that the reduction of TRP levels induced by the acute administration of a TRPfree amino acid mixture decreases d-fenfluramine-induced ( Fig. 2 ) and spontaneous ( Fig. 3 ) release of 5-HT in the hippocampus of freely moving rats. Moreover, when a TRP-free diet is administered for 5 days, there is a progressive and marked decrease in the release of 5-HT. In rats treated with a TRP-free diet, at the fifth day of dieting 5-HT was not detectable in the hippocampus ( Fig. 4 ) (unpublished observations). The reduction of extracellular content of 5-HT in control rats was due to a glial reaction around the dialysis tube. In conclusion, a decrease in brain TRP concentration reduces 5-HT synthesis and subsequently its release.
The mechanism through which the administration of a TRP-free amino acid diet causes the reduction of plasmatic TRP, and consequently brain TRP and 5-HT synthesis, has been suggested by Gessa et al. (6) . These researchers hypothesized that protein synthesis is the major mechanism causing a TRP decrease in the blood. The amino acids administered with the diet induce protein synthesis at tissue levels. During the protein synthesis, the tissues should utilize the extracellular endogenous TRP, thus lowering its concentration ( Fig. 1B) . To verify this hypothesis, researchers have studied the effect of the ingestion of the TRP-free diet in rats previously treated with a protein synthesis inhibitor, cycloheximide. The blockade of protein synthesis after administration of increasing doses of cycloheximide blocks the decrease of plasmatic TRP induced by the TRP-free diet (6) . Another mechanism that contributes to the reduction of brain TRP after the acute ingestion of a TRP-free diet is that TRP competes for the same carrier system that transports all of the LNAAs across the blood-brain barrier. However, it has been found that, following administration of the six neutral amino acids, the effect on brain TRP is very slight, thus suggesting that the competition at the blood-brain barrier is a relatively minor factor in decreasing brain 5-HT (5, 6) .
Behavioral effects of TRP depletion
The TRP-free amino acid diet offers a nonpharmacological means for effectively decreasing brain 5-HT function. With respect to other antagonists, the advantage of this method lies in its high specificity and nontoxicity. Therefore, this selective method for lowering central serotonergic activity has been extensively used both in laboratory animals and humans to study the role of 5-HT in a variety of physiological and behavioral functions, such as macronutrient selection, pain sensitivity, aggressiveness, sleep, sexual behavior, mood, anxiety, and memory and learning. A short review of documented behavioral and physiological effects is given below.
Macronutrients selection. It has been observed that animals are able to spontaneously choose a balanced amount of macronutrients. This observation suggested the existence of a possible brain control mechanism for food selection. It is well known that diet influences the concentration of TRP in the brain and therefore the concentration of 5-HT. The ingestion of proteins diminishes rat brain TRP and 5-HT, because all of the LNAAs compete with TRP for transportation across the blood-brain barrier. Conversely, carbohydrate consumption increases TRP and 5-HT in the brain because the ingestion of carbohydrates induces an increase in blood insulin, which in turn increases the uptake of the branched chain amino acids (leucine, isoleucine, and valine) into muscle, thus decreasing their plasmatic concentration and competition at the bloodbrain barrier. Since proteins and glucides have opposite effects on brain 5-HT, these fluctuations in 5-HT can control the relative intake of proteins and glucides. In confirmation of this hypothesis, the acute administration of a TRP-free amino acid mixture increased carbohydrate selection, whereas a glucide meal supplemented with TRP markedly increases protein selection in laboratory animals.
The effect of a TRP-free amino acid mixture on food selection has also been studied in humans (15) . In this study, human subjects ingested a TRP-free amino acid mixture or a nutritionally balanced one. Five hours after ingestion of the mixtures, subjects were allowed to choose different foods from a buffet. The TRP-free mixture was associated with a decrease in protein selection, but not in carbohydrates, fat, or total calories. The decline in protein selection observed in humans is consistent with the decrease in protein selection observed in laboratory animals, thus suggesting that brain 5-HT may be involved in the control of the choice of macronutrients in humans as well.
Pain sensitivity. In laboratory animals, the TRP depletion method confirms data obtained by using serotonergic antagonists: a reduction of pain perception threshold. The acute administration of a TRP-free amino acid mixture as well as the chronic administration of food deficient in TRP causes an increase in pain sensitivity in laboratory animals. Together, these findings confirm the hypothesis that 5-HT is implicated in sensitivity to painful stimuli (3).
Aggressiveness. Mouse-killing behavior is considered an index of aggressiveness in rats. Mouse-killing behavior was induced in nonkiller rats and was facilitated in killer rats kept on a TRP-free diet for 4-6 days (see Ref. 12 ). This increased killing behavior was associated with a reduction in brain 5-HT and 5-HIAA. Different research groups, using several models of aggression (i.e., shock-induced fighting, pain sensitivity, and muricide behavior), confirmed that such a diet increases aggressiveness in rats. Increased aggressiveness and irritability has also been observed in monkeys after the administration of a TRP-free amino acid mixture. More recently, a significant increase in aggressive response was found in healthy human subjects with the use of an aggression paradigm, after the administration of a TRP-free amino acid mixture (8) . These results are consistent with the hypothesis that brain 5-HT neurons exert inhibitory control over aggressive behavior.
Sleep. With the use of pharmacological manipulations, a role of the serotonergic system has been demonstrated in sleep, though the results are not univocal. The acute administration of a TRP-free amino acid mixture, prepared as described in our previous report (2) , causes in humans a decrease in stage 4 sleep latency and an increase in stage 4 sleep, but REM sleep did not change significantly (7) . In rats, on the other hand, a significant decrease of REM sleep was found (7) . Although the total sleep duration in rat and human did not significantly change, the different effect of the diet in the rat and human may be due to a different role of 5-HT in the regulation of sleep.
Sexual behavior. It has been well known since the middle of 1960s that the pharmacological reduction of serotonergic activity induces compulsive sexual activity in laboratory animals. On the basis of this finding, different research groups have utilized diets either deficient in or lacking TRP to reveal possible effects on sexual behavior. It has been demonstrated that a TRP-free diet produced a significant increase in maleto-male mounting behavior both in rats and rabbits (4) . Similarly, a TRP-deficient diet facilitates the copulatory behavior of male rats with females in estrus. These results clearly demonstrate that 5-HT plays an inhibitory role in sexual behavior. Interestingly, food deficient in TRP, such as corn, may have aphrodisiac properties.
Mood. Young et al. (14) first demonstrated that the ingestion of a TRP-free amino acid mixture causes a rapid lowering of mood in normal male subjects. This result has also been observed in healthy men with a multigenerational family history of major affective disorders. Moreover, the acute ingestion of a TRP-free amino acid mixture may have a transient depressive effect in drug-remitted depressed patients (see below). Other studies performed on normal women confirm what was found in men. However, women appear to be more susceptible than men to the depressive effect induced by TRP depletion.
Memory and learning. Recently, we found that the TRP-free diet does not affect avoidance learning nor spatial memory performance in rats, although it did diminish the release of 5-HT in the hippocampus and cortex (11) . In contrast to the results obtained in animals, Riedel et al. (10) found an impairment of memory consolidation in healthy volunteers with or without a positive family history of depression. These researchers observed a lowering mood effect in subjects with a positive family history of depression but not in the other group. However, in mentally normal males with high levels of anxiety, the acute ingestion of a TRP-free amino-acid mixture maintains anxiety, which is reduced after a balanced diet is restored (2) . On the other hand, TRP depletion also causes a lowering of mood. It has been suggested that these psychological effects may have a negative effect on the performance of an accuracy task (see Ref. 11) . Further studies with a larger number of subjects are needed to confirm the data obtained in humans.
Acute TRP depletion in some psychiatric disturbances
The last decade has seen the investigation of the effect of short-term TRP depletion in some psychopathological disturbances, in which experimental evidence suggests that they are related to 5-HT dysfunction. For example, in drug-remitted depressed patients, depressive relapses have been observed following ingestion of a TRP-free amino acid mixture, with a gradual return to a normal mood when patients returned to a normal diet. In women with premenstrual syndrome, TRP depletion causes an augmented irritability, anxiety, and overreactivity. In bulimic patients, the TRP-free amino acid mixture enhanced dysphoria as well as anxiety. It has been suggested that these effects may be due to decreased 5-HT release in the brain. On the other hand, in other psychiatric disturbances in which the 5-HT system appears to be important, no effect has been observed after acute TRP depletion. For example, patients with obsessive-compulsive disorders did not significantly change their mean rating of obsession and compulsion subsequent to acute ingestion of TRP-free amino acid mixture. In patients with panic disorder, TRP depletion was not anxiogenic or panicogenic. In these cases, other neurotransmitter systems as well as 5-HT are probably implicated.
In conclusion, the TRP depletion paradigm is used at present as a specific and nontoxic method for evaluating effects produced by a temporary reduction of 5-HT function in humans. The TRP depletion method could be used to study behavior in which the role of 5-HT is unknown. Finally, other neurotransmitters may be influenced by diet (i.e., dopamine, noradrenaline, and acetylcholine) by manipulating their precursors. Diets lacking phenylalanine or choline may be used as a tool to study the physiological and behavioral effects produced by a reduction of the respective neurotransmitters, similarly to what is found for 5-HT.
I am most grateful to R. Stancampiano for precious collaboration and critical reading of the manuscript. I thank M. Ibba for help in constructing Fig. 1 . I apologize to the authors of many important contributions that could not be cited due to space limitations. S ince corticotropin-releasing factor (CRF) was isolated and characterized by Vale and co-workers (13) at the Salk Institute, peripheral cardiovascular actions of CRF have been observed across species ranging from rodents to humans. However, scientists have been perplexed by the relevance of these cardiovascular actions, since very low levels of CRF normally circulate in peripheral blood and relatively low levels of CRF gene expression are observed in the heart. It is well accepted that CRF is the primary hormone involved in the mammalian response to stress (2, 14) and produces central actions to increase blood pressure and stimulate pituitary adrenocorticotropic hormone (ACTH) and adrenal steroid release in all species studied. CRF belongs to a family of structurally related peptides that includes fish urotensin 1 and amphibian sauvagine, which also possess bioactivity similar to CRF in several mammalian systems. In 1993, the discovery of a high-affinity receptor for CRF (1) added to the acceptance of CRF as a physiologically relevant hormone present in the central nervous system and pituitary blood supply. However, lack of any significant expression of this CRF type 1 receptor (CRF-R1) in peripheral tissues relevant to control of the cardiovascular system did not support the hypothesis that circulating CRF may be directly controlling the heart or vasculature. In 1994, a second CRF receptor was cloned and characterized, and tissue expression of this type 2 receptor (CRF-R2) was reported soon thereafter. A splice variant of this type 2 receptor, CRF receptor type 2β (CRF-R2β), is present in both brain and peripheral tissues, including the heart, testis, and gastrointestinal tract. Recently, a third splice variant of the CRF-R2 was isolated, CRF-R2γ, and this receptor is expressed in human brain regions, including the hippocampus and septum (Fig. 1 ).
Isolation and characterization of urocortin
In 1995, Vaughan and colleagues (15) described the discovery of a CRF-related peptide expressed in rat brain known as urocortin (Ucn), named after its peptide homology to both the teleost hormone urotensin and to mammalian CRF and because it possesses biological activity exhibited by both of these peptides. Rat Ucn is a 40 amino acid peptide with 45% homology to rat/human CRF, 63% homology to teleost urotensin 1, and 35% homology to frog sauvagine (Fig. 2 ) (15) . The urotensin-like immunoreactivity possessed by Ucn enabled its initial identification within a discrete region of the rat midbrain known as the Edinger-Westphal nucleus, a region that lacks expression of CRF mRNA. Ucn cDNA was isolated from an mRNA library derived from rat midbrain, which was screened with a urotensin probe. The full-length cDNA encodes a protein deduced to be 122 amino acids in length. The carboxy terminus contains Ucn, a putatively cleaved 40 amino acid peptide with a carboxy terminal amidation. Recently, the sequence of ovine Ucn was published and is identical to that for the rat peptide.
Vaughan and colleagues also reported Ucn to have marked cardiovascular actions in rats to lower blood pressure and increase heart rate, with a greater potency and duration of
